QuikChange II XL Site-Directed Mutagenesis Kit, 10 Rxn

Site Directed Mutagenesis (SDM) Human - Deletion K562 c-Myb gene

Experiment
Site Directed Mutagenesis (SDM) Human - Deletion K562 c-Myb gene
Product
QuikChange II XL Site-Directed Mutagenesis Kit, 10 Rxn from Agilent Technologies
Manufacturer
Agilent Technologies

Protocol tips

Upstream tips
- XL10-Gold cells are resistant to tetracycline and chloramphenicol. If the mutagenized plasmid contains only the tetR or camR resistance marker, an alternative strain of competent cells must be used.
Protocol tips
- Use only the Dpn I enzyme provided; do not substitute with an enzyme from another source.

Publication protocol

Plasmids
Mig-RI-c-Myb-HA and Mig-RI-Δ(358–452)c-Myb were obtained as described.

Cells and culture conditions
293T cells and parental and derivative K562 cell lines were maintained as described. Derivative K562 cell lines (Δ(358–452)c-Myb, p89, c-Myb shRNA or c-Myb shRNA expressing p89_shMUT or p75_shMUT) were established by retroviral infection and isolation of green fluorescent protein-positive cells or selection with puromycin.

Transient transfection and dual-luciferase reporter assay
The Mig-RI Δ(358–452)c-Myb or p89 (3 μg) was co-transfected with cyclin B1-Luc-pGL3 or SLUG-Luc-pGL3 (1 μg) and Renilla luciferase (0.02 μg) into 10 K562 cells using nucleofector kit V (Amaxa; Lonza Group, Basel, Switzerland) according to the manufacturer's protocol. After 48 h, cells were diluted 1:5 in fresh medium and cultured for an additional 6–8 h. Cells were then lysed (100 μl of passive lysis buffer; Promega, Madison, WI, USA) and Firefly and Renilla luciferase activities were measured on a luminometer using the dual-luciferase reporter assay kit (Promega). For the assay in 293T cells, cells were seeded into six-well plates at 5 × 10 cells per well. The following day, DNA (5 μg of reporter plasmid, 5 μg of effector plasmid and 0.5 μg of Renilla luciferase) was transfected using ProFection Mammalian Transfection System-Calcium Phosphate (Promega) following the manufacturer's protocol. Cells were washed 16 h after transfection and incubated in fresh medium for an additional 24 h. At 40 h post transfection, cells were lysed in 500 μl of passive lysis buffer per well (Promega) and Firefly and Renilla luciferase activities were measured as described. All the measurements were performed in triplicate.

Full paper   Login or join for free to view the full paper.

Reviews

QuikChange II XL Site-Directed Mutagenesis Kit, 10 Rxn from Agilent Technologies has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Site Directed Mutagenesis (SDM) Human - Deletion K562 c-Myb gene using QuikChange II XL Site-Directed Mutagenesis Kit, 10 Rxn from Agilent Technologies.

Paper title
Expression of p89, an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells
Full paper
Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Agilent Technologies for QuikChange II XL Site-Directed Mutagenesis Kit, 10 Rxn below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Site Directed Mutagenesis (SDM) Human - Deletion K562 c-Myb gene using QuikChange II XL Site-Directed Mutagenesis Kit, 10 Rxn from Agilent Technologies. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms